fate therapeutics stock price target

Analysts consensus targets ratings and recommendations Nasdaq. The forecasts range from a low of 2800 to a high of.

Ykjjjorote Tlm

Forecast target price for 11-06-2022.

. 27 rows The Trend in the Analyst Price Target. This is 453 less than the trading day before Tuesday 1st Nov 2022. NASDAQFATE concluded the trading at 2004 on Wednesday November 02 with a fall of -453 from its closing price on previous day.

The current analyst and expert consensus on Fate Therapeutics is Buy with 0 strong sell and 14 strong buy opinions. Price Target Based on short-term price targets offered by 16 analysts the average price target for Fate Therapeutics comes to 7313. Cantor Fitzgeralds target price would suggest a potential upside of 13136 from the companys current price.

04 2022 GLOBE NEWSWIRE -- Fate Therapeutics Inc. FATE a clinical-stage biopharmaceutical. Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate.

20 hours agoCantor Fitzgerald analyst Li Watsek assumes Fate Therapeutics NASDAQFATE with a Overweight rating and lowers Price Target of 45. The Company or Fate Therapeutics NASDAQ. Positive dynamics for Fate Therapeutics shares will prevail with possible.

The analyst firm set a price target for 3500 expecting. 12 hours agoSAN DIEGO Nov. SAN DIEGO Nov.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen AMGN Research Report Fate Therapeuti. ET by Tomi Kilgore Fate Therapeutics stock price target raised to 65 from 40 at Truist. Fate Therapeutics stock price target raised to 88 from 55 at Wedbush Dec.

Close price at the end of the last trading day Wednesday 2nd Nov 2022 of the FATE stock was 2004. FATE has been the topic of a number of other research reports. FATE updated stock price target summary.

The current projected Fate Therapeutics target price consensus is 10387. Stock Price Target FATE. Fate Therapeutics Inc.

Fate Therapeutics Stock Forecast 11-06-2022. FATE reports an average of 16285 for its upside potential over. FATE a clinical-stage biopharmaceutical.

FATE THERAPEUTICS INC. 04 2022 GLOBE NEWSWIRE -- Fate Therapeutics Inc. Target values for the price of one Fate Therapeutics share for May 2026.

7 2020 at 718 am. According to 28 stock analysts the average 12-month stock price forecast for FATE stock is 7291 which predicts an increase of 26382. The Company or Fate Therapeutics NASDAQ.

FATE was reported by Morgan Stanley on September 9 2022. According to 8 Wall Street analyst s that have issued a 1 year FATE price target the average FATE price target is 7150 with the highest FATE stock price forecast at 11500 and the lowest. The weighted average target price per Fate Therapeutics share in May 2026 is.

Stock Price Forecast. Analyst ratings historical stock prices earnings estimates actuals. Over the past 48 weeks FATEs average price target has gone down 3991.

The latest price target for Fate Therapeutics NASDAQ.

Markets Cmn Markets January 2022 Crispr Stocks And Market News